Does Ubs own SLN stock?

Yes. As of its Q2 2026 13F, Ubs holds 243,152 shares of SLN (Silence Therapeutics), worth $2.7M.

How many shares of SLN does Ubs own?

As of its Q2 2026 13F, Ubs holds 243,152 shares of SLN (Silence Therapeutics).

As of its Q2 2026 13F, Ubs' SLN position is worth $2.7M.

In Q2 2026, Ubs reduced its SLN position by 3,785 shares (-1.5%).

Ubs first reported SLN in its Q4 2020 13F and has listed it in 20 quarterly 13F filings.

Position history for UBS Group AG's holdings in SILENCE THERAPEUTICS PLC

Current Value

$2.7M

Current Shares

243,152

Total Value Change

+$2.7M

Total Shares Change

+243,059

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	243,152	-1.5%	$2.7M	0.0%	$10.98	0
2026-Q1	Increased	246,937	+19.0%	$1.3M	0.0%	$5.66	30
2025-Q4	Decreased	207,513	-32.5%	$1.3M	0.0%	$6.15	0
2025-Q3	Increased	307,363	+34.5%	$1.6M	0.0%	$5.67	33
2025-Q2	Decreased	228,509	-28.5%	$1.3M	0.0%	$5.79	0
2025-Q1	Decreased	319,514	-10.3%	$901,029	0.0%	$3.44	0
2024-Q4	Increased	356,071	+403.9%	$2.4M	0.0%	$6.91	42
2024-Q3	Decreased	70,661	-4.3%	$1.3M	0.0%	$18.25	0
2024-Q2	Increased	73,806	+2.6%	$1.4M	0.0%	$19.00	26
2024-Q1	Increased	71,918	+2.8%	$1.6M	0.0%	$21.60	26
2023-Q4	Increased	69,946	+1.2%	$1.2M	0.0%	$17.37	26
2023-Q3	Decreased	69,113	-1.4%	$678,690	0.0%	$9.82	0
2023-Q2	Increased	70,130	+1.6%	$385,715	0.0%	$5.81	24
2023-Q1	Unchanged	69,006	0.0%	$427,837	0.0%	$6.30	0
2022-Q4	Increased	69,006	+4.8%	$1.1M	0.0%	$15.25	26
2022-Q3	Decreased	65,815	-5.0%	$660,000	0.0%	$10.00	0
2022-Q2	Decreased	69,255	-0.2%	$821,000	0.0%	$12.81	0
2022-Q1	Decreased	69,368	-1.2%	$1.3M	0.0%	$19.48	0
2021-Q4	New	70,218	-	$1.7M	0.0%	$24.00	36
2021-Q1	Exited	0	-100.0%	$0	0.0%	$22.95	0
2020-Q4	New	93	-	$2,000	0.0%	$21.88	17